Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 35 Records) |
| Query Trace: Thrombosis and MPL[original query] |
|---|
| [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients]. Medicina clínica 2015 Mar 144 (6): 247-53. Angona Anna, Alvarez-Larrán Alberto, Bellosillo Beatriz, Martínez-Avilés Luz, Garcia-Pallarols Francesc, Longarón Raquel, Ancochea Àgueda, Besses Carl |
| Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
| Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia. Annals of hematology 2014 Dec 93 (12): 2029-36. Chen Chih-Cheng, Gau Jyh-Pyng, Chou Hui-Ju, You Jie-Yu, Huang Cih-En, Chen Yi-Yang, Lung Jrhau, Chou Yi-Sheng, Leu Yu-Wei, Lu Chang-Hsien, Lee Kuan-Der, Tsai Ying-Hua |
| Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history. European journal of haematology 2015 Jan 94 (1): 31-6. Gangat Naseema, Wassie Emnet A, Lasho Terra L, Finke Christy, Ketterling Rhett P, Hanson Curtis A, Pardanani Animesh, Wolanskyj Alexandra P, Maffioli Margherita, Casalone Rosario, Passamonti Francesco, Tefferi Ayal |
| Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia 2014 Dec 28 (12): 2300-3. Tefferi A, Wassie E A, Lasho T L, Finke C, Belachew A A, Ketterling R P, Hanson C A, Pardanani A, Gangat N, Wolanskyj A |
| CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood 2014 Apr 123 (15): 2416-9. Rumi Elisa, Harutyunyan Ashot S, Pietra Daniela, Milosevic Jelena D, Casetti Ilaria C, Bellini Marta, Them Nicole C C, Cavalloni Chiara, Ferretti Virginia V, Milanesi Chiara, Berg Tiina, Sant'Antonio Emanuela, Boveri Emanuela, Pascutto Cristiana, Astori Cesare, Kralovics Robert, Cazzola Mario, |
| Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status. European journal of haematology 2015 Jun . Mela Osorio María J, Ferrari Luciana, Goette Nora P, Gutierrez Marina I, Glembotsky Ana C, Maldonado Ana C, Lev Paola R, Alvarez Clarisa, Korin Laura, Marta Rosana F, Molinas Felisa C, Heller Paula |
| Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis. Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
| Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis. Leukemia 2015 Jun 29 (6): 1344-9. Palandri F, Latagliata R, Polverelli N, Tieghi A, Crugnola M, Martino B, Perricone M, Breccia M, Ottaviani E, Testoni N, Merli F, Aversa F, Alimena G, Cavo M, Martinelli G, Catani L, Baccarani M, Vianelli |
| JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis. Pathology oncology research : POR 2015 Jul 21 (3): 751-8. Pósfai Éva, Marton Imelda, Király Péter Attila, Kotosz Balázs, Kiss-László Zsuzsanna, Széll Márta, Borbényi Zi |
| Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study. Chinese medical journal 0 129 (15): 1778-1783. Sun Chao, Zhou Xin, Zou Zhi-Jian, Guo Hong-Feng, Li Jian-Yong, Qiao Ch |
| Thrombotic risk correlates with mutational status in true essential thrombocythemia. European journal of clinical investigation 2016 Jun . Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi M |
| PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status. Thrombosis research 2016 Apr 140 Suppl 1 S183. Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden P E J, Swieringa F, Ten Cate H, Heemskerk J W M, Rambaldi A, Falanga |
| Molecular biomarkers of thrombosis in myeloproliferative neoplasms. Thrombosis research 2016 Apr 140 Suppl 1 S71-5. Barbui Tiziano, Falanga An |
| Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia. American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
| Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 2016 12 129 (6): 680-692. Rumi Elisa, Cazzola Mar |
| Genetic Risk Assessment in Myeloproliferative Neoplasms. Mayo Clinic proceedings 2017 8 92 (8): 1283-1290. Tefferi Ayalew, Vannucchi Alessandro Mar |
| Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study. Journal of hepatology 2017 May . Poisson Johanne, Plessier Aurélie, Kiladjian Jean-Jacques, Turon Fanny, Cassinat Bruno, Andreoli Annalisa, De Raucourt Emmanuelle, Goria Odile, Zekrini Kamal, Bureau Christophe, Lorre Florence, Cervantes Francisco, Colomer Dolors, Durand François, Garcia-Pagan Juan-Carlos, Casadevall Nicole, Valla Dominique-Charles, Rautou Pierre-Emmanuel, Marzac Christophe, |
| [Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance]. Zhongguo shi yan xue ye xue za zhi 2017 Feb 25 (1): 151-156. Tang Qin, Zhang Xiu-Wen, Xia Lei, Jiang Nai- |
| Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors. Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
| Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis. Journal of hepatology 2020 Jul . Magaz Marta, Alvarez-Larrán Alberto, Colomer Dolors, López-Guerra Mónica, García-Criado M Ángeles, Mezzano Gabriel, Belmonte Ernest, Olivas Pol, Soy Guillem, Cervantes Francisco, Darnell Anna, Ferrusquía-Acosta José, Baiges Anna, Turon Fanny, Hernández-Gea Virginia, García-Pagán Juan Carl |
| Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis. Annals of hematology 2021 8 100 (11): 2699-2706. Yang Erpeng, Wang Mingjing, Wang Ziqing, Li Yujin, Wang Xueying, Ming Jing, Xiao Haiyan, Quan Richeng, Liu Weiyi, Hu Xiaom |
Whole genome sequence analysis of platelet traits in the NHLBI Trans-Omics for Precision Medicine (TOPMed) initiative.
Human molecular genetics 2021 9 31 (3): 347-361. Little Amarise, Hu Yao, Sun Quan, Jain Deepti, Broome Jai, Chen Ming-Huei, Thibord Florian, McHugh Caitlin, Surendran Praveen, Blackwell Thomas W, Brody Jennifer A, Bhan Arunoday, Chami Nathalie, de Vries Paul S, Ekunwe Lynette, Heard-Costa Nancy, Hobbs Brian D, Manichaikul Ani, Moon Jee-Young, Preuss Michael H, Ryan Kathleen, Wang Zhe, Wheeler Marsha, Yanek Lisa R, Abecasis Goncalo R, Almasy Laura, Beaty Terri H, Becker Lewis C, Blangero John, Boerwinkle Eric, Butterworth Adam S, Choquet Hélène, Correa Adolfo, Curran Joanne E, Faraday Nauder, Fornage Myriam, Glahn David C, Hou Lifang, Jorgenson Eric, Kooperberg Charles, Lewis Joshua P, Lloyd-Jones Donald M, Loos Ruth J F, Min Yuan-I, Mitchell Braxton D, Morrison Alanna C, Nickerson Deborah A, North Kari E, O'Connell Jeffrey R, Pankratz Nathan, Psaty Bruce M, Vasan Ramachandran S, Rich Stephen S, Rotter Jerome I, Smith Albert V, Smith Nicholas L, Tang Hua, Tracy Russell P, Conomos Matthew P, Laurie Cecelia A, Mathias Rasika A, Li Yun, Auer Paul L, , Thornton Timothy, Reiner Alexander P, Johnson Andrew D, Raffield Laura |
| Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases. Blood cancer journal 2022 3 12 (3): 44. Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
| Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
| The effects of pathogenic variants for inherited hemostasis disorders in 140,214 UK Biobank participants. Blood 2023 8 . Luca Stefanucci, Janine H Collins, Matthew Christopher Sims, Iñigo Barrio-Hernandez, Luanluan Sun, Oliver Burren, Livia Perfetto, Isobel Bender, Tiffany J Callahan, Kathryn Fleming, Jose Antonio Guerrero, Henning Hermjakob, Maria J Martin, James David Stephenson, Kalpana Paneerselvam, Slavé Petrovski, Pablo Porras, Peter N Robinson, Quanli Wang, Xavier Watkins, Mattia Frontini, Roman A Laskowski, Pedro Beltrao, Emanuele Di Angelantonio, Keith Gomez, Michael Laffan, Willem H Ouwehand, Andrew D Mumford, Kathleen Freson, Keren Jacqueline Carss, Kate Downes, Nicholas S Gleadall, Karyn Megy, Elspeth Bruford, Dragana Vuckov |
| MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology (Amsterdam, Netherlands) 2023 6 28 (1): 2229131. Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komat |
| Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort. Annals of hematology 2023 4 . Daniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, Marta Lionetti, Elisa Fermo, Valentina Bellani, Claudio De Magistris, Akihiro Maeda, Alessio Marella, Massimo Primignani, Dario Consonni, Umberto Gianelli, Antonino Neri, Luca Baldini, Niccolò Bolli, Alessandra Iur |
| Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: